William Blair & Company’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-132,413
| Closed | -$556K | – | 1896 |
|
|
2023
Q1 | $556K | Hold |
132,413
| – | – | ﹤0.01% | 1005 |
|
|
2022
Q4 | $796K | Sell |
132,413
-43,785
| -25% | -$239K | ﹤0.01% | 902 |
|
|
2022
Q3 | $1.02M | Hold |
176,198
| – | – | ﹤0.01% | 808 |
|
|
2022
Q2 | $1.05M | Hold |
176,198
| – | – | ﹤0.01% | 830 |
|
|
2022
Q1 | $823K | Sell |
176,198
-100,000
| -36% | -$298K | ﹤0.01% | 986 |
|
|
2021
Q4 | $685K | Buy |
276,198
+100,000
| +57% | +$245K | ﹤0.01% | 1093 |
|
|
2021
Q3 | $520K | Buy |
176,198
+100,000
| +131% | +$272K | ﹤0.01% | 1144 |
|
|
2021
Q2 | $190K | Hold |
76,198
| – | – | ﹤0.01% | 1518 |
|
|
2021
Q1 | $222K | Hold |
76,198
| – | – | ﹤0.01% | 1447 |
|
|
2020
Q4 | $245K | Sell |
76,198
-13
| -0% | -$43 | ﹤0.01% | 1351 |
|
|
2020
Q3 | $164K | Hold |
76,211
| – | – | ﹤0.01% | 1353 |
|
|
2020
Q2 | $88K | Hold |
76,211
| – | – | ﹤0.01% | 1389 |
|
|
2020
Q1 | $70K | Buy |
76,211
+25,000
| +49% | +$28.7K | ﹤0.01% | 1356 |
|
|
2019
Q4 | $81K | Hold |
51,211
| – | – | ﹤0.01% | 1439 |
|
|
2019
Q3 | $43K | Buy |
51,211
+13
| +0% | +$10 | ﹤0.01% | 1470 |
|
|
2019
Q2 | $44K | Hold |
51,198
| – | – | ﹤0.01% | 1514 |
|
|
2019
Q1 | $50K | Hold |
51,198
| – | – | ﹤0.01% | 1467 |
|
|
2018
Q4 | $38K | Hold |
51,198
| – | – | ﹤0.01% | 1424 |
|
|
2018
Q3 | $111K | Hold |
51,198
| – | – | ﹤0.01% | 1374 |
|
|
2018
Q2 | $255K | Buy |
+51,198
| New | +$224K | ﹤0.01% | 1184 |
|
|
2018
Q1 | – | Sell |
-51,198
| Closed | -$137K | – | 1643 |
|
|
2017
Q4 | $137K | Buy |
+51,198
| New | +$150K | ﹤0.01% | 1300 |
|
|
2017
Q3 | – | Sell |
-51,198
| Closed | -$169K | – | 1614 |
|
|
2017
Q2 | $169K | Hold |
51,198
| – | – | ﹤0.01% | 1374 |
|
|
2017
Q1 | $216K | Hold |
51,198
| – | – | ﹤0.01% | 1197 |
|
|
2016
Q4 | $209K | Hold |
51,198
| – | – | ﹤0.01% | 1146 |
|
|
2016
Q3 | $192K | Hold |
51,198
| – | – | ﹤0.01% | 1176 |
|
|
2016
Q2 | $174K | Buy |
+51,198
| New | +$235K | ﹤0.01% | 1133 |
|
Other funds holding CTIC
William Blair & Company's CTIC Position: Q2 2023 in Review
William Blair & Company sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q2 2023, closing a stake of 132,413 shares — an estimated $556K sold.
William Blair & Company first reported a position in CTIC in Q2 2016 and held it in 26 quarters. The position peaked at $1.05M in Q2 2022. 2 funds tracked by Wall St. Rank hold CTIC as of Q2 2023.
- William Blair & Company reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q2 2023 after selling out during the quarter.
- William Blair & Company sold 132,413 CTI BioPharma Corp. (DE) Common Stock shares in Q2 2023, an estimated $556K.
- William Blair & Company first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q2 2016 and held it in 26 quarters.
- William Blair & Company's CTI BioPharma Corp. (DE) Common Stock position peaked at $1.05M in Q2 2022.
- 2 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q2 2023.
Based on William Blair & Company's 13F filing for Q2 2023, filed 11 Aug 2023.